These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 34917685)
1. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study. Al-Rawaf HA; Alghadir AH; Gabr SA Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685 [TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity. Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052 [TBL] [Abstract][Full Text] [Related]
3. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters. García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469 [TBL] [Abstract][Full Text] [Related]
4. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients. Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583 [TBL] [Abstract][Full Text] [Related]
5. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes. Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209 [TBL] [Abstract][Full Text] [Related]
6. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index. Zang H; Jiang F; Cheng X; Xu H; Hu X Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965 [TBL] [Abstract][Full Text] [Related]
7. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus. Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV Bone; 2022 May; 158():116308. PubMed ID: 35066213 [TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study. Zeinali F; Aghaei Zarch SM; Jahan-Mihan A; Kalantar SM; Vahidi Mehrjardi MY; Fallahzadeh H; Hosseinzadeh M; Rahmanian M; Mozaffari-Khosravi H PLoS One; 2021; 16(6):e0251697. PubMed ID: 34077450 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D Deficiency and Molecular Changes in Circulating MicroRNAs in Older Adults with Lower Back Pain. Al-Rawaf HA; Gabr SA; Alghadir AH Pain Res Manag; 2021; 2021():6662651. PubMed ID: 34055120 [TBL] [Abstract][Full Text] [Related]
10. The effects of supervised aerobic training on dyslipidaemia among diabetic older patients. Alghadir AH; Gabr SA; Iqbal A BMC Endocr Disord; 2024 Oct; 24(1):212. PubMed ID: 39385223 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients. El Samaloty NM; Hassan ZA; Hefny ZM; Abdelaziz DHA Arab J Gastroenterol; 2019 Mar; 20(1):1-7. PubMed ID: 30852102 [TBL] [Abstract][Full Text] [Related]
12. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Nunez Lopez YO; Garufi G; Seyhan AA Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909 [TBL] [Abstract][Full Text] [Related]
13. The Potential Relationship Between Serum Irisin Concentration With Inflammatory Cytokines, Oxidative Stress Biomarkers, Glycemic Indices and Lipid Profiles in Obese Patients With Type 2 Diabetes Mellitus: A Pilot Study. Khajebishak Y; Faghfouri AH; Soleimani A; Ilaei S; Peyrovi S; Madani S; Payahoo L J ASEAN Fed Endocr Soc; 2023; 38(1):45-51. PubMed ID: 37252420 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial. Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105 [TBL] [Abstract][Full Text] [Related]
16. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399 [TBL] [Abstract][Full Text] [Related]
17. Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysis. Kałużna M; Hoppe K; Schwermer K; Ibrahim AY; Pawlaczyk K; Ziemnicka K Pol Arch Med Wewn; 2016 Jul; 126(7-8):474-82. PubMed ID: 27452672 [TBL] [Abstract][Full Text] [Related]
18. Circulating IRAPe, Irisin, and IL-34 in Relation to Insulin Resistance in Patients With Type 2 Diabetes. Mostafa TM; El-Gharbawy NM; Werida RH Clin Ther; 2021 Jul; 43(7):e230-e240. PubMed ID: 34103176 [TBL] [Abstract][Full Text] [Related]
19. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439 [TBL] [Abstract][Full Text] [Related]
20. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Corral-Fernández NE; Salgado-Bustamante M; Martínez-Leija ME; Cortez-Espinosa N; García-Hernández MH; Reynaga-Hernández E; Quezada-Calvillo R; Portales-Pérez DP Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):347-53. PubMed ID: 23616185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]